Arundhati sits down with Larry Wood, the Corporate Vice President, TAVR with Edwards Lifesciences. Larry talks about how transcatheter valve replacement has revolutionized the treatment of aortic stenosis. He also shares what the future of aortic stenosis is and what people should look forward to in the next ten years. Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Larry Wood http://edwards.com/ 

Arundhati welcomes Julia Hu, the CEO of Lark Health. They speak about conversational AI and how it can support chronic disease management and improve patient outcomes. Julia also shares the beliefs of Lark Health in solving the different health issues today. She also talks about the different programs of Lark Health and how they help clients. Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Julia Hu https://www.lark.com/ 

Arundhati interviews Carolyn With, the co-founder and CEO of the startup company, Tia. Together, they discuss the biggest pain points in women’s healthcare today and the health inquiries that exist in the space. Carolyn also shares how Tia is tackling these problems, as well as its recent achievements and their growth plans.   Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ 

Reporters at MedCity News discuss their coverage areas interests and share what pitches are interesting and what is not. Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ 

Arundhati interviewed Sarah Boyce, CEO of Avidity Biosciences. In October 2019, Sarah Boyce joined Avidity as President and CEO, and she serves as a member of the board of directors. Ms. Boyce brings to Avidity extensive operational, commercial and leadership experience in the life sciences industry and has built global organizations, bringing a number of innovative therapies including Tegsedi®, Waylivra®, Soliris®, Gleevec® and Tasigna® to patients. Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Sarah Boyce https://www.linkedin.com/in/sarah-boyce-7775808/ http://www.aviditybiosciences.com/about-us/ 

Arundhati interviewed Dr. Robert Pearl who has written a book about how physician culture needs to be urgently reformed to benefit both patients and the healthcare industry. Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Dr. Robert Pearl drrobertpearl@gmail.com https://robertpearlmd.com/uncaring/ 

Arundhati interviewed Dr. Erich Huang, Chief Data Officer for Quality at Duke Health, and the Director of Duke Forge. They talk about why more hospitals are implementing machine learning tools for healthcare, and the challenges of ensuring these models do not yield biased results. Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Dr. Erich Huang https://forge.duke.edu/erich-s-huang-md-phd https://www.linkedin.com/in/erichhuang/ 

Arundhati interviewed Glen Tullman to talk about his new venture and how he wants to transform the employee benefits and care navigation market. Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ 

Arundhati interviewed Ho Cho, senior vice president of Discovery Biotherapeutics at BMS talking about drug discovery and the interesting therapies that BMS is developing to treat myeloma and lupus. Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Ho Cho https://www.linkedin.com/in/ho-cho-9173162/ 

Arundhati interviews Sean Slovenski, CEO of BioiQ, and they talk about how Covid-19 has affected the world of diagnostics and at-home testing. Episode Resources Connect with Arundhati Parmar aparmar@medcitynews.com https://twitter.com/aparmarbb?lang=en https://medcitynews.com/ Connect with Sean Slovenski sslovenski@bioiq.com tj@thinkrevivehealth.com